EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and …
GC Drosos, D Vedder, E Houben, L Boekel… - Annals of the …, 2022 - ard.bmj.com
Objective To develop recommendations for cardiovascular risk (CVR) management in gout,
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …
Comorbidities and health-related quality of life in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
C Mercuzot, S Letertre, CI Daien, L Zerkowski… - Autoimmunity …, 2021 - Elsevier
Background and objectives The optimization of immunosuppressive therapies has led to a
marked improvement in the survival of ANCA-associated vasculitides (AAV). The main issue …
marked improvement in the survival of ANCA-associated vasculitides (AAV). The main issue …
2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] Updates in ANCA-associated vasculitis
C Ross, JP Makhzoum, C Pagnoux - Eur J Rheumatol, 2022 - eurjrheumatol.org
Antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) are small-vessel
vasculitides that include granulomatosis with polyangiitis (formerly Wegener's …
vasculitides that include granulomatosis with polyangiitis (formerly Wegener's …
[HTML][HTML] Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic …
JR van Leeuwen, EL Penne, T Rabelink… - Computers in Biology …, 2024 - Elsevier
Background Because anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitis
(AAV) is a rare, life-threatening, auto-immune disease, conducting research is difficult but …
(AAV) is a rare, life-threatening, auto-immune disease, conducting research is difficult but …
[HTML][HTML] Impact of cardiovascular risk factors on the occurrence of cardiovascular events in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides
C Roubille, S Henriquez, C Mercuzot, C Duflos… - Journal of Clinical …, 2021 - mdpi.com
Despite improvement in the prognosis of ANCA-associated vasculitides (AAVs), increased
mortality, mainly from a cardiovascular origin, persists. We aimed to determine the role of …
mortality, mainly from a cardiovascular origin, persists. We aimed to determine the role of …
[HTML][HTML] Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis: A prospective, two-centre cohort study
Y Vegting, EL Penne, ML Hilhorst, T Hoekstra… - Joint Bone Spine, 2023 - Elsevier
Objectives ANCA-associated vasculitis (AAV) has been associated with increased risk of
cardiovascular (CV) events. The aim was to assess traditional and disease-related CV risk …
cardiovascular (CV) events. The aim was to assess traditional and disease-related CV risk …
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in ANCA-Associated Vasculitis: A Multinational Retrospective Study
S Moiseev, N Bulanov, M Crnogorac… - The Journal of …, 2023 - jrheum.org
Objective To investigate the occurrence of cardiovascular events (CVEs) in a large cohort of
patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across …
patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across …
Predictors of fatal and non-fatal cardiovascular events in ANCA-associated vasculitis: data from the Toronto CanVasc cohort
E Houben, A Mendel, S Carette, AE Voskuyl, EL Penne… - Joint Bone Spine, 2020 - Elsevier
Objectives Patients with ANCA-associated vasculitis are at increased risk of cardiovascular
events. The aim of the present study was to assess predictors of cardiovascular events in …
events. The aim of the present study was to assess predictors of cardiovascular events in …
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective …
S Moiseev, N Bulanov, M Crnogorac… - The Journal of …, 2023 - jrheum.org
Objective To investigate the occurrence of cardiovascular events (CVEs) in a large cohort of
patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across …
patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across …